, Influenza (Seasonal); c2018
The burden of influenza B: a structured literature review, American journal of public health, vol.103, issue.3, p.3673513, 2013. ,
,
, Sistema de Vigilancia de la Gripe en España, pp.2017-2018
,
, , pp.2001-2018
,
,
, Gac Sanit, vol.29, issue.4, pp.258-65, 2015.
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries, Vaccine, vol.24, pp.6812-6834, 2006. ,
Seasonal influenza in Spain: Clinical and economic burden and vaccination programmes, Med Clin (Barc), vol.153, issue.1, pp.16-27, 2019. ,
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, BMC Infect Dis, vol.18, issue.1, p.5994061, 1999. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01925131
The evolving history of influenza viruses and influenza vaccines, Expert Rev Vaccines, vol.12, issue.9, pp.1085-94, 2013. ,
The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe?, Euro Surveill, vol.22, issue.35, p.5587899, 2017. ,
The rationale for quadrivalent influenza vaccines, Human Vaccines & Immunotherapeutics, vol.8, issue.1, pp.81-89, 2012. ,
The coming era of quadrivalent human influenza vaccines: who will benefit?, Drugs, vol.72, issue.17, pp.2177-85, 2012. ,
,
, Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia, vol.28, pp.39-46, 2015.
,
, European Centre for Disease Prevention and Control [Internet]. Seasonal influenza vaccination in Europe-Vaccination recommendations and coverage rates for 2013-14 and 2014-15; c2016
,
, Datos Estadísticos, 2018.
, WHO recommendations on the composition of influenza virus vaccines
, Risk assessment for seasonal influenza, 2017.
, Haut Conseil de la Santé Publique
, Grippe saisonnière: utilisation des vaccins quadrivalents inactivés; c2014
, Joint Committee on Vaccination and Immunisation
,
, Wissenschaftliche Begründung fü r die Empfehlung des quadrivalenten saisonalen Influenzaimpfstoffs; c2018, Epidemiologisches Bulletin
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. The Journal of infectious diseases, vol.199, pp.159-67, 2008. ,
Methods for the economic evaluation of health care programmes, 2015. ,
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe, Hum Vaccin Immunother, vol.12, issue.9, pp.2259-68, 2016. ,
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol.15, pp.828-862, 2012. ,
Dynamic versus static models in cost-effectiveness analyses of antiviral drug therapy to mitigate an influenza pandemic. Health economics, vol.19, pp.518-549, 2010. ,
Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective, Statistics in medicine, vol.18, issue.23, pp.3263-82, 1999. ,
Dynamic modelling approaches for the analysis of the cost-effectiveness of seasonal influenza control. Expert Rev Vaccines, vol.16, 2017. ,
A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert review of pharmacoeconomics & outcomes research, vol.17, pp.249-65, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01548937
Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses, vol.9, p.4549101, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02460755
Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol.19, pp.964-75, 2016. ,
Social contacts and mixing patterns relevant to the spread of infectious diseases, PLoS Med, vol.5, issue.3, p.2270306, 2008. ,
Time lines of infection and disease in human influenza: a review of volunteer challenge studies, American journal of epidemiology, vol.167, issue.7, pp.775-85, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02668741
, Principales series de población desde 1998, pp.1998-2018
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports, vol.55, pp.1-42, 2006. ,
The annual impact of seasonal influenza in the US: measuring disease burden and costs, Vaccine, vol.27, issue.25, pp.5086-96, 2007. ,
Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials, Vaccine, vol.31, issue.1, pp.49-57, 2012. ,
,
, Enferm Infecc Microbiol Clin, vol.33, issue.1, pp.22-28, 2015.
,
,
Conjunto Mínimo Bá sico de Datos-Hospitalización (CMBD-H), pp.1997-2015 ,
Temporada gripal 2001-02 en una consulta de Pediatría en Atención Primaria. Bol S Vasco-Nav Pediatr, vol.36, pp.5-8, 2002. ,
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom, Eur J Clin Microbiol Infect Dis, vol.19, issue.11, pp.834-876, 2000. ,
, Oblikue consulting [Internet]. eSalud-Informació n económica del sector sanitario; c2007
, Consejo General de Colegios Oficiales de Farmacé uticos
Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study, PLoS ONE, vol.7, issue.2, p.31696, 2012. ,
, Instituto Nacional de Estadística
, , pp.2009-2016
Morano Larragueta R. Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain, Hum Vaccin Immunother, vol.12, issue.9, pp.2269-77, 2016. ,
Impact of influenza on healthrelated quality of life among confirmed (H1N1)2009 patients, PLoS One, vol.8, issue.3, p.60477, 2013. ,
, Instituto Nacional de Estadística
, Hipó tesis nacionales de evolució n demográ, 2018.
Spanish recommendations on economic evaluation of health technologies. The European journal of health economics: HEPAC: health economics in prevention and care, vol.11, p.20405159, 2010. ,
,
, BDCAP, pp.2011-2016
Recommendations of the Panel on Costeffectiveness in Health and Medicine, Jama, vol.276, issue.15, pp.1253-1261, 1996. ,
Towards a new approach for estimating indirect costs of disease, Social science & medicine, vol.34, issue.9, p.1631600, 1982. ,
A practical guide for calculating indirect costs of disease, PharmacoEconomics, vol.10, issue.5, pp.460-466, 1996. ,
The establishment-level behaviour of vacancies and hiring, Q J Econ, vol.128, pp.581-622, 2013. ,
Update of the Dutch manual for costing studies in health care, PLoS One, vol.12, issue.11, p.5679627, 2017. ,
The friction cost method for measuring indirect costs of disease, J Health Econ, vol.14, issue.2, pp.44-49, 1995. ,
Guía y recomendaciones para la realizació n y presentació n de evaluaciones econó micas y aná lisis de impacto presupuestario de medicamentos en el á mbito del CatSalut, Barcelona: Servei Català de la Salut, 2014. ,
Valor Monetario de un Año de Vida Ajustado por Calidad: Estimación empírica del coste de oportunidad en el Sistema Nacional de Salud ,
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England, BMC medicine, vol.15, issue.1, p.166, 2017. ,
Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? Applied health economics and health policy, vol.14, p.4871927, 2016. ,
Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination, PharmacoEconomics, vol.26, issue.1, pp.45-56, 2008. ,
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community, PharmacoEconomics, vol.34, issue.3, p.4766233, 2016. ,
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes ResearchTask Force Report, Value in Health, vol.21, issue.10, pp.1133-1182, 2018. ,
WHO guide on the economic evaluation of influenza vaccination. Influenza Other Respir Viruses, vol.12, p.5820425, 2018. ,
, European Centre for Disease Prevention and Control
, Antimicrobial resistance surveillance in, Europe, 2016.